Vol. 63 No. 2 (2017), ORIGINAL ARTICLES. B. EXPERIMENTAL RESEARCH

Vol. 63 No. 2 (2017)

HARMONIZED STATISTICAL ANALYSIS OF THE EFFICACY OF INTRAPERITONEAL CHEMOTHERAPY REGIMENS WITH DIOXADET ON ASCITIC OVARIAN CANCER MODEL

ORIGINAL ARTICLES. B. EXPERIMENTAL RESEARCH

https://doi.org/10.37469/0507-3758-2017-63-2-329-335

Published 01.02.2017

Vladimir Bespalov⁺⁻
Aleksey Belyaev⁺⁻
Denis Baranenko⁺⁻
Nikita Khromov-borisov⁺⁻
Valeriy Aleksandrov⁺⁻
Larisa Krasilnikova⁺⁻
Galina Kireeva⁺⁻
Olesya Belyaeva⁺⁻
Konstantin Senchik⁺⁻
Aleksandr Stukov⁺⁻
Irina Vasileva⁺⁻
Aleksandr Semenov⁺⁻
Grigoriy Tochilnikov⁺⁻
Ivan Alvovskiy⁺⁻
Ye. Vyshinskaya⁺⁻

Vladimir Bespalov

N.N. Petrov Research Institute of Oncology, ITMO University

Aleksey Belyaev

N.N. Petrov Research Institute of Oncology, I.I. Mechnikov North-West State Medical University

Denis Baranenko

ITMO University

Nikita Khromov-borisov

R.R. Vreden Russian Scientific Research Institute of Traumatology and Orthopedics

Valeriy Aleksandrov

N.N. Petrov Research Institute of Oncology, ITMO University

Larisa Krasilnikova

N.N. Petrov Research Institute of Oncology

Galina Kireeva

N.N. Petrov Research Institute of Oncology

Olesya Belyaeva

N.N. Petrov Research Institute of Oncology

Konstantin Senchik

N.N. Petrov Research Institute of Oncology

Aleksandr Stukov

N.N. Petrov Research Institute of Oncology

Irina Vasileva

N.N. Petrov Research Institute of Oncology, ITMO University

Aleksandr Semenov

N.N. Petrov Research Institute of Oncology, ITMO University

Grigoriy Tochilnikov

N.N. Petrov Research Institute of Oncology, ITMO University

Ivan Alvovskiy

N.N. Petrov Research Institute of Oncology, ITMO University

Ye. Vyshinskaya

N.N. Petrov Research Institute of Oncology

##article.numberofdownloads## 73

##article.numberofviews## 254

PDF (Русский)

Keywords

INTRAPERITONEAL CHEMOTHERAPY
NORMOTHERMIC AND HYPERTHERMIC INTRAPERITONEAL CHEMOPERFUSION
OVARIAN CANCER
DIOXADET

How to Cite

Bespalov, V., Belyaev, A., Baranenko, D., Khromov-borisov, N., Aleksandrov, V., Krasilnikova, L., Kireeva, G., Belyaeva, O., Senchik, K., Stukov, A., Vasileva, I., Semenov, A., Tochilnikov, G., Alvovskiy, I., & Vyshinskaya, Y. (2017). HARMONIZED STATISTICAL ANALYSIS OF THE EFFICACY OF INTRAPERITONEAL CHEMOTHERAPY REGIMENS WITH DIOXADET ON ASCITIC OVARIAN CANCER MODEL. Voprosy Onkologii, 63(2), 329–335. https://doi.org/10.37469/0507-3758-2017-63-2-329-335

Abstract

A comparative statistical study of the results of eight independent experiments on the efficacy of intraperitoneal chemotherapy has been performed. The regiments of cathether intraperitoneal chemotherapy (CIPC), normothermic and hyperthermic chemoperfusion (NIPEC and HIPEC) with antitumor drug dioxadet were investigated in 288 female Wistar rats with ascitic ovarian cancer. Ovarian cancer was transplanted intra-peritoneally (i.p.) 48 hours prior to a single chemotherapy at a number of 1*107 tumor cells. Dioxadet was administered at the maximum tolerated doses: CIPC - via syringe - 1.5 mg/kg body weight; NIPEC (36,5-37,5°С) and HIPEC (40,5-41,5°С) - infused for a continuous circulation using an experimental setting - at respective doses 30 and 15 mg/kg body weight. The rats in the control groups were administered in the same manner with physiological saline solution. The antitumor effects of the treatment were estimated as an increase in survival time. The statistical analysis was based on the principles of harmonization of statistical evidence and predictions. The mean survival time in the control group without treatment (i.p. saline injection) was 15 days with 95% confidence interval (CI) from 12 to 19 days. IPC, NIPEC and HIPEC increased mean survival time by 85, 97 and 202% (p<0.001 for the all cases) compared to the control group without treatment. Thus, HIPEC is the most effective mode of i.p. chemotherapy with antitumor drug dioxadet.

https://doi.org/10.37469/0507-3758-2017-63-2-329-335

##article.numberofdownloads## 73

##article.numberofviews## 254

PDF (Русский)

References

Беляева О.А., Беспалов В.Г., Сенчик К.Ю. и др. Химиоперфузионное лечение канцероматоза брюшной полости. - СПб., 2016. - 146 с.

Беспалов В.Г., Вышинская Е.А., Васильева И.Н. и др. Интраперитонеальная химиотерапия - путь повышения эффективности лечения рака яичника // Вопр. онкол. - 2015. - Т. 61. - № 4. - C. 634-641.

Беспалов В.Г., Киреева Г.С., Беляева О.А. и др. Интраоперационное внутрибрюшинное химиоперфузионное лечение цисплатином и диоксадэтом на модели канцероматоза брюшной полости при раке яичника: оценка безопасности и эффективности // Вопр. онкол. - 2015. - Т. 61. - № 4. - C. 647-652.

Вышинская Е.А., Беспалов В.Г., Васильева И.Н. и др. Преимущества интраперитонеальной химиотерапии в лечении канцероматоза брюшной полости при раке яичника // Ж. акуш. и жен. болезн. - 2014. - Т. 63. -№ 2. - С. 28-34.

Гершанович М.Л., Филов В.А., Котова Д.Г. и др. Результаты кооперированного клинического изучения противоопухолевого препарата диоксадэт по II фазе // Вопр. онкол. - 1998. - T.44. - № 2. - С. 216-220.

Стуков А.Н., Гершанович М.Л., Беспалов В.Г. и др. Классификация противоопухолевых препаратов // Медлайн-Экспресс. - 2012. - № 2. - C. 20-24.

Хромов-Борисов Н.Н. Гармонизация статистических доказательств и предсказаний в биомедицине // I Открытый российский статистический конгресс: Сборник докладов. - Новосибирск: НГУЭУ, 2016. - C. 39-53.

Ansaloni L., Coccolini F., Morosi L. et al. Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer // Br. J. Cancer. - 2015. - Vol. 112. - P. 306-312.

Bespalov V.G., Kireeva G.S., Belyaeva O.A. et al. Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model // J. Surg. Oncol. - 2016. -Vol. 113. - P. 438-442.

Bespalov V.G., Kireeva G.S., Belyaeva O.A. et al. Experimental study of antitumour activity and effects on leukocyte count of intraperitoneal administration and hyperthermic intraperitoneal chemoperfusion (HIPEC) with dioxadet in a rat model of ovarian cancer // J. Chemother. - 2016. - Vol. 28. - P. 203-209.

Boisen M.M., Richard S.D., Holtzman M.P. et al. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role? // J. Gastrointest. Oncol. - 2016. - Vol. 7. - P. 10-17.

Bookman M.A. Optimal primary therapy of ovarian cancer // Ann. Oncol. - 2016. - Suppl. 1. - P. 58-62.

Chan D.L., Morris D.L., Rao A., Chua T.C. Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy // Cancer Manag. Res. - 2012. - Vol. 4. - P. 413-422.

Faul F., Erdfelder E., Buchner A., Lang A.G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses // Behav. Res. Methods. - Vol. 41. - P. 1149-1160.

Ferlay J., Soerjomataram I., Ervik M. et al. GLOBOCAN 2012 v. 1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base № 11. Электронный ресурс. URL: http://glo-bocan.iarc.fr/Default.aspx (дата обращения: 13.07.2016).

Gourley C., Walker J.L., Mackay H.J. Update on intraperi-toneal chemotherapy for the treatment of epithelial ovarian cancer // Am. Soc. Clin. Oncol. Educ. Book. - 2016. - Vol. 35. - P. 143-151.

Grosso G., Rossetti D., Coccolini F. et al. Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey // Arch. Gynecol. Obstet. - 2014. - Vol. 290. - P. 425-422.

Hammer 0., Harper D., Ryan P. PAST: paleontological statistics software package for education and data analysis // Palaeontol. Electron. - 2001. - Vol. 4. - P. 4-9.

ICMJE. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. - 2015. Электронный ресурс. URL: http:// www.icmje.org/recommendations

Jaaback K., Johnson N., Lawrie T.A. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer // Cochrane Database Syst. Rev. - 2016. - 1:CD005340.

Love J., Selker R., Marsman M. et al. «JASP» Computer software. - Version 0.6.6. - 2015.

Narod S. Can advanced-stage ovarian cancer be cured? // Nat. Rev. Clin. Oncol. - 2016. - Vol. 13. -P. 255-261.

Polom K., Roviello G., Generali D. et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer // Int. J. Hyperthermia. -2016. - Vol. 32. - P. 298-310.

Wasserstein R.L., Lazar N.A. The ASA>s Statement on p-Values: Context, Process, and Purpose // Am. Stat. -2016. - Vol. 70. - P. 129-133.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Galina Kireeva, Stepan Kruglov, A. Tarasov, Ye. Plakhov, Yekaterina Gubareva, Mikhail Maydin, Andrey Panchenko, Tatyana Grishacheva, MODIFICATING ACTION OF DICLOFENAC ON EFFECTS OF PHOTODYNAMIC THERAPY – IN VIVO STUDY , Voprosy onkologii : Vol. 65 No. 3 (2019)
Igor Berlev, Anna Sidoruk, Olga Smirnova, Nikolay Bondarev, Olga Lavrinovich, Nikolay Mikaya, Yelena Ulrikh, Adiliya Urmancheeva, M. Yakoveva, Yekaterina Nekrasova, Irina Meshkova, Aleksandr Ivantsov, Aleksey Belyaev, Aleksey Karachun, Tatyana Gorodnova, Andrey Domanskiy, Yuriy Pelipas, Katran Guseynov, Zaur Ibragimov, Anna Sokolenko, N. Matveeva, CYTOREDUCTIVE SURGERY WITH PERITONECTOMY IN PATIENTS WITH OVARIAN CANCER: TECHNICAL ASPECTS AND IMMEDIATE RESULTS , Voprosy onkologii : Vol. 64 No. 3 (2018)
Yevgeniya Kharchenko, Tatyana Semiglazova, Anna Artemeva, Galina Kireeva, I. Polyatskin, Ilya Zyuzgin, Larisa Filatova, Yuliya Chudinovskikh, Margarita Motalkina, Yuliya Oleynik, PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL AND MOLECULAR GENETIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA , Voprosy onkologii : Vol. 66 No. 1 (2020)
Aleksey Belyaev, Georgiy Prokhorov, Viktoriya Zakharova, CRYOGENIC TECHNOLOGY IN MINIMALLY INVASIVE TREATMENT OF BREAST CANCER. LITERATURE REVIEW , Voprosy onkologii : Vol. 66 No. 2 (2020)
Anton Barchuk, A. Atroshchenko, V. Gaydukov, P. Vinogradov, Sergey Tarakanov, Sergey Kanaev, Andrey Arsenev, Yuriy Komarov, Mikhail Kharitonov, Aleksey Barchuk, Vakhtang Merabishvili, Vladimir Kuznetsov, Vladimir Trofimov, Nataliya Gusarova, Igor Kotsyuba, Aleksey Belyaev, Maksim Podolskiy, A. Nefedova, AUTOMATED DIAGNOSIS IN A POPULATION-BASED SCREENING FOR LUNG CANCER , Voprosy onkologii : Vol. 63 No. 2 (2017)
Vladimir Semiglazov, Ye. Trufanova, Pavel Krzhivitskiy, Aleksey Belyaev, Aleksandra Kondakova, Sergey Yereshchenko, Yelena Zhiltsova, Andrey Mishchenko, Viktoriya Bashlyk, Asel Kudaybergenova, Veronika Klimenko, Anna Artemeva, Vladislav Semiglazov, Yekaterina Busko, Aleksandr Komyakhov, Tatyana Semiglazova, Garik Dashyan, Petr Krivorotko, A. Tseluyko, CLINICAL AND BIOLOGICAL MODEL FOR EVALUATION OF THE EFFECTIVENESS OF SYSTEMIC THERAPY FOR BREAST CANCER , Voprosy onkologii : Vol. 64 No. 3 (2018)
Anton Barchuk, K. Gagua, S. Tarkov, A. Nefedova, Andrey Nefedov, Aleksandr Shcherbakov, Aleksey Barchuk, Sergey Kanaev, Viktor Gombolevskiy, Aleksey Belyaev, Andrey Arsenev, K. Kostitsyn, THE EFFECTIVENESS OF SCREENING FOR CANCER , Voprosy onkologii : Vol. 63 No. 4 (2017)
Yevgeniy Imyanitov, Aleksey Belyaev, Aleksandr Shcherbakov, Lev Bershteyn, Aleksandr Bessonov, Petr Krivorotko, Tatyana Gorodnova, Khristina Kotiv, Igor Berlev, Anna Sokolenko, Vladimir Semiglazov, PRESENCE OF BRCA1 AND BRCA2 IN HEALTHY WOMEN AND MEN: DNA TESTING, DIAGNOSTIC ACTIVITIES AND CANCER PREVENTION , Voprosy onkologii : Vol. 63 No. 2 (2017)
Tatyana Semiglazova, Natalya Buevich, Yekaterina Anokhina, Yevgeniya Kharchenko, Mikhail Osipov, Veronika Klimenko, Margarita Motalkina, Yuriy Komarov, Gulfiya Teletaeva, Dilorom Latipova, Sergey Alekseev, Larisa Filatova, Aleksey Novik, Anna Semenova, Irina Baldueva, Aleksandr Stukov, Svetlana Protsenko, Z. Kotova, HOW APPROACHES TO DRUG THERAPY FOR MALIGNANT TUMORS HAVE CHANGED (TO THE FIRST DOMESTIC ANTITUMOR DRUG IS DEDICATED) , Voprosy onkologii : Vol. 63 No. 2 (2017)
Aleksey Belyaev, Georgiy Prokhorov, Zamira Radzhabova, Olga Baykalova, CONTEMPORARY TREATMENT APPROACH OF SQUAMOUS CELL SKIN CANCER: REVIEW , Voprosy onkologii : Vol. 65 No. 1 (2019)

<< < 1 2 3 4 5 > >>